Respiratory syncytial virus infection in children with congenital heart disease: A review

Pediatric Cardiology

Volumn 17, Issue 3, 1996, Pages 163-168

  Fixler, D E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Congenital heart disease; Respiratory syncytial virus; RSV passive immunization; RSV vaccines

Indexed keywords

RIBAVIRIN; VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PASSIVE IMMUNIZATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK ASSESSMENT; VACCINATION; VIRUS INFECTION;

EID: 0029876409     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02505206     Document Type: Article

References (40)

1. Albert RK, Condie F (1981) Hand-washing patterns in medical intensive-care units. N Engl J Med 304:1465-1466
2. Bruhn FW, Yeager AS (1977) Respiratory syncytial virus in early infancy: circulating antibody and the severity of infection Am J Dis Child 131:145-148
3. Collins P, Davis A, Lubeck M, et al (1989) Evaluation of the protective efficacy of recombinant vaccinia viruses and adenoviruses that express respiratory syncytial virus glycoproteins. In: Modern Approaches to New Vaccines Including Prevention of AIDS. Abstracts of 1989 meeting, September 1989. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, p 26
4. Committee on Infectious Disease (1987) Ribavirin therapy of respiratory syncytial virus. Pediatrics 79:475-476
5. Garner JS, Simmons BP (1983) Guideline for isolation precautions in hospitals. Infect Control 4(Suppl):245-325
6. Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL (1981) Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 95:708-715
7. Glezen WP, Taber LH, Frank AL, Kasel JA (1986) Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 740-543-546
8. Groothuis JR, Simoes EAF, Levin MJ, et al (1993) Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 329:1524-1530
9. Groothuis JR, Woodin KA, Katz R, et al (1990) Early ribavirin treatment of respiratory syncytial viral infection m high-risk children. J Pediatr 117:792-798
10. Hall CB (1992) Respiratory syncytial virus. In. Feigin RD, Cherry JD (eds) Textbook of Pediatric Infection Disease, 3rd edn Saunders, Philadelphia, pp 1663-1756
11. Hall CB, McBride JT, Gala CL, Heldreth SW, Schnabel KC (1985) Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA 254:3041-3051
12. Hall CB, McBride JT, Walsh EE, et al (1983) Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: a randomized double-blind study. N Engl J Med 305:1443-1447
13. Hemming VG, Prince GA, London WT, et al (1988) Topically administered immunoglobulin reduces pulmonary respiratory syncytial virus shedding in owl monkeys. Antimicrob Agents Chemother 52:1269-1270
14. Hemming VG, Prince GA, Rodriguez W, et al (1988) Respiratory syncytial virus infections and intravenous gamma-giobulins Pediatr Infect Dis J 7(Suppl): 103-506
15. Hemming VG, Rodriguez W, Kim HW, et al (1987) Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother 31:1882-1886
16. Henderson FW, Collier AM, Clyde WA Jr. Denny FW (1979) Respiratory syncytial virus infections, reinfections and immunity: a prospective longitudinal study in young children. N Engl J Med 500:530-534
17. Hughes JH, Mann DR, Hamparian W (1988) Detection of respiratory syncytial virus in clinical specimens by viral culture, direct and indirect immunofluorescence. and enzyme immunoassay. J Clin Microbiol 26:588-592
18. Kapikian AZ, Mitchell RH, Chanock RM, Shevdoff RA, Stewart CE (1969) An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 89:405-421
19. Kellogg JA (1991) Culture vs direct antigen assays for detection of microbial pathogens from lower respiratory tract specimens suspected of containing the respiratory syncytial virus. Arch Pathol Lab Med 115:451-458
20. Kim HW, Arrobio JO, Brandt CD, et al (1973) Safety and antigenicity of temperature-sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children. Pediatrics 52:56-63
21. Kim HW, Canchola JG, Brandt CD, et al (1969) Respiratory syncytial virus disease in infants despite prior administration of an antigenic inactivated vaccine. Am J Epidemiol 89:422-434
22. Kim HW, Leikin SL, Arrobio J, et al (1986) Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Pediatr Res 10:75-78
23. Lamprecht CL, Krause HE, Mufson MA (1976) Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. J Infect Dis 134:211-211
24. Leclair JM, Freeman J, Sullivan BF, Crowley CM, Goldmann DA (1987) Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med 317:329-334
25. MacDonald NE, Hall CB, Suffin SC, et al (1982) Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 507:397-400
26. MeIntosh K (1993) Respiratory syncytial virus - successful immunoprophylaxis at last. N Engl J Med 329:1572-1574
27. Meert K, Heidemann S, Lieh-Lai M, Sarnaik AP (1989) Clinical characteristics of respiratory syncytial virus infections in healthy versus previously compromised host. Pediatr Pulmonol 7:167-170
28. Meissner HC, Fulton DR, Groothuis JR (1993) Controlled trial to evaluate protection of high risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin. Antimicrob Agents Chemother 37:1655-1658
29. Moler FW, Khan AS, Meliones JN, et al (1992) Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience. Crit Care Med 20:1406-1413
30. Murphy BR, Graham BS, Prince GA, et al (1986) Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol 23:1009-1014
31. Navas L, Wang E, de Carvalho V, et al (1992) Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J Pediatr 727:348-354
32. Ogilvie MM, Vathenen AS, Radford M, Codd J, Key S (1981) Maternal antibody and respiratory syncytial virus infection in infancy. J Med Virol 7:263-271
33. Olsen MA, Shuck KM, Sambol AR (1993) Evaluation of Abbott TestPack RSV for the diagnosis of respiratory syncytial virus infections. Diagn Microbiol Infect Dis 16:105-109
34. Parrott RH, Kim HW, Arrobio JO, et al (1973) Epidemiology of respiratory syncytial virus infection in Washington. DC, II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol 98:289-300
35. Prince GA, Hemming VG, Horswood RL, Chanock RM (1985) Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Res 3:193-206
36. Smith DW, Frankel LR, Mathers LH, et al (1991) A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial infection. N Engl J Med 325:24-29
37. Stretton M, Ajizian SJ, Mitchell I, Newth CJL (1992) Intensive care course and outcome of patients infected with respiratory syncytial virus. Pediatr Pulmonol 73:143-150
38. Tristam DA, Welliver RC, Mohar CK, et al (1993) Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old. J Infect Dis 167:191-195
39. Ward KA, Lambden PR, Ogilvie MM, Watt PJ (1983) Antibodies to respiratory syncytial virus polypeptides and their significance in human infection. J Gen Virol 64:1867-1876
40. Wright PF, Shinozaki T, Fleet W, et al (1976) Evaluation of live, attenuated respiratory syncytial virus vaccine in infants. J Pediatr 88:931-936